John McBride
Direktor/Vorstandsmitglied bei ELEDON PHARMACEUTICALS, INC.
Vermögen: - $ am 31.05.2024
Profil
John S.
McBride was the founder of Alliance Life Sciences Consulting Group, Inc. (founded in 1994) where he served as President from 2017 to 2019.
He is currently working as an Independent Director at Eledon Pharmaceuticals, Inc. since 2017.
In his former positions, McBride worked as a Director at Niiki Pharma, Inc. and Intezyne Technologies, Inc. He also held the position of Principal at Eastman Kodak Co. and Head-Oncology Licensing at Pfizer Inc. Additionally, he served as Vice President-Commercial Development at Sparta Pharmaceuticals, Inc. and Vice President-Business Development at U.S.
Bioscience, Inc. McBride was also the Treasurer & Vice President-Business Development at Phytera, Inc. From 2009 to 2012, McBride held the role of Chief Operating Officer & Executive Vice President at Gloucester Pharmaceuticals, Inc. He was the Global Head-Oncology Licensing at Pharmacia Corp.
and Chief Financial Officer & Executive Vice President at CytoTherapuetics, Inc. From 2014 to 2017, he served as the Chief Operating & Financial Officer at Tokai Pharmaceuticals, Inc. McBride also worked as a Principal at Atlantic Richfield Corp.
and Chief Financial Officer at Cadent Therapeutics, Inc. from 2019 to 2021.
In terms of education, McBride completed his undergraduate and graduate degrees at the University of Wisconsin.
He also holds an MBA from The Wharton School of the University of Pennsylvania.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.05.2024 | 0 ( -.--% ) | - $ | 31.05.2024 |
Aktive Positionen von John McBride
| Unternehmen | Position | Beginn |
|---|---|---|
| ELEDON PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.05.2017 |
Ehemalige bekannte Positionen von John McBride
| Unternehmen | Position | Ende |
|---|---|---|
Cadent Therapeutics, Inc.
 Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | Finanzdirektor/CFO | 01.03.2021 |
Alliance Life Sciences Consulting Group, Inc.
 Alliance Life Sciences Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Alliance Life Sciences Consulting Group, Inc. provides management and technology consultancy services. It offers strategic and management consulting, operations consulting, program management, business process improvement, application development, and testing and mobile development. The company was founded in 1994 and is headquartered in Somerset, NJ. | Gründer | 01.08.2019 |
Tokai Pharmaceuticals, Inc.
 Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | Finanzdirektor/CFO | 01.01.2017 |
Niiki Pharma, Inc.
 Niiki Pharma, Inc. Pharmaceuticals: OtherHealth Technology Niiki Pharma, Inc. manufactures chemicals and botanical products. It specializes in cancer treatments directed at novel cellular targets and related companion diagnostics. The company was founded by Hooshmand Sheshbaradaran, Ardakana Ali and Jay Z. Zhang in 2007 and is headquartered in Hoboken, NJ. | Direktor/Vorstandsmitglied | 01.06.2013 |
Gloucester Pharmaceuticals, Inc.
 Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gloucester Pharmaceuticals, Inc. develops products for the treatment of cancer patients. Its programs include cutaneous T-cell lymphoma (CTCL), peripheral T-cell lymphoma (PTCL), and multiple myeloma. The company was founded in May 2003 and is headquartered in Cambridge, MA | Geschäftsführer | 01.01.2012 |
Ausbildung von John McBride
| University of Wisconsin | Graduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| EASTMAN KODAK COMPANY | Producer Manufacturing |
| PFIZER, INC. | Health Technology |
| ELEDON PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 12 |
|---|---|
Sparta Pharmaceuticals, Inc.
 Sparta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Sparta Pharmaceuticals, Inc. acquires the rights to, and develops for commercialization, technologies and drugs for the treatment of diseases. The company is based in Horsham, PA. Sparta Pharmaceuticals was acquired by SuperGen, Inc. on August 13, 1999 for $12.28 million. The company was founded by Peter N. Christos. | Health Technology |
U.S. Bioscience, Inc.
 U.S. Bioscience, Inc. BiotechnologyHealth Technology U.S. Bioscience, Inc. is a pharmaceutical company specializing in the development and commercialization of products for patients with cancer and AIDS and allied infections. The company has three products on the market. In addition to its headquarters, U.S. Bioscience has a manufacturing facility located in Nijmegen, The Netherlands, an analytical laboratory in Exton, PA, and a subsidiary near London to coordinate clinical trials in Europe. U.S. Bioscience, Inc. is headquartered in West Conshohocken, PA. | Health Technology |
Phytera, Inc.
 Phytera, Inc. Miscellaneous Commercial ServicesCommercial Services Phytera, Inc. develops plant-based and marine-based pharmaceuticals. The company is headquartered in Shrewsbury, MA. | Commercial Services |
Gloucester Pharmaceuticals, Inc.
Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gloucester Pharmaceuticals, Inc. develops products for the treatment of cancer patients. Its programs include cutaneous T-cell lymphoma (CTCL), peripheral T-cell lymphoma (PTCL), and multiple myeloma. The company was founded in May 2003 and is headquartered in Cambridge, MA | Health Technology |
Niiki Pharma, Inc.
Niiki Pharma, Inc. Pharmaceuticals: OtherHealth Technology Niiki Pharma, Inc. manufactures chemicals and botanical products. It specializes in cancer treatments directed at novel cellular targets and related companion diagnostics. The company was founded by Hooshmand Sheshbaradaran, Ardakana Ali and Jay Z. Zhang in 2007 and is headquartered in Hoboken, NJ. | Health Technology |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
| CytoTherapuetics, Inc. | Finance |
Tokai Pharmaceuticals, Inc.
Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | Health Technology |
Atlantic Richfield Corp.
 Atlantic Richfield Corp. Forest ProductsNon-Energy Minerals Part of BP Plc, Atlantic Richfield Corp. provides logging services. | Non-Energy Minerals |
Alliance Life Sciences Consulting Group, Inc.
Alliance Life Sciences Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Alliance Life Sciences Consulting Group, Inc. provides management and technology consultancy services. It offers strategic and management consulting, operations consulting, program management, business process improvement, application development, and testing and mobile development. The company was founded in 1994 and is headquartered in Somerset, NJ. | Commercial Services |
Intezyne Technologies, Inc.
 Intezyne Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Intezyne Technologies, Inc. develops therapeutic and diagnostic technologies. The firm is a clinical stage biotechnology company. The company was founded by Habib Skaff and Kevin N. Sill in 2004 and is headquartered in Tampa, FL. | Commercial Services |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | Health Technology |